ARCHIVES

FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat.

This article is from The Cancer Letter archive.

Vol. 30 No. 06 | February 6, 2004

Download PDF Visit The Full Archive

Related Articles

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

DRCCA’s New Board Of Scientific Counselors to Meet Sept. 18-19

August 22, 1980

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

The Cancer Letter To End Print Edition In January

November 20, 2009